Related Experiment Video
Updated: Sep 4, 2025

08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
Nab-Paclitaxel related cystoid macular edema
M Di Pippo1, F Di Staso1, C De Ponte2
1Ophthalmology Unit, Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, University of Rome Sapienza, St. Andrea Hospital, Rome, Italy.
La Clinica Terapeutica
|July 20, 2022
Summary
Nab-paclitaxel can cause cystoid macular edema (CME), leading to vision loss. Drug cessation is preferred, but topical treatments offer effective alternatives when discontinuation isn't feasible.
Area of Science:
- Ophthalmology
- Oncology
- Pharmacology
Background:
- Nab-paclitaxel is a chemotherapy agent for solid tumors, designed to reduce paclitaxel's toxicity.
- Despite formulation improvements, nab-paclitaxel can cause ocular adverse effects, notably cystoid macular edema (CME).
Related Concept Videos
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Angle Closure Glaucoma: Treatment
641
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
641

